Blood Urea Nitrogen/Creatinine Ratio and Response to Tolvaptan in Patients with Decompensated Heart Failure: A Retrospective Analysis

Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure<SUBTITLE>The EVEREST Outcome Trial</SUBTITLE>

Marvin A. Konstam · JAMA · 2007 · 1.6K citations

Medicine, Pharmacology, Pharmacotherapy +16

Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).

Gary S. Francis, Claude R. Benedict, David E. Johnstone et al. · Circulation · 1990 · 1.4K citations

Medicine, Cardiology, Physiology +10

Vasopressin V ₂ -Receptor Blockade With Tolvaptan in Patients With Chronic Heart Failure

Mihai Gheorghiade, Imran Khan Niazi, John Ouyang et al. · Circulation · 2003 · 430 citations

Medicine, Pharmacology, Pharmacotherapy +17

Blood Urea Nitrogen/Creatinine Ratio Identifies a High-Risk but Potentially Reversible Form of Renal Dysfunction in Patients With Decompensated Heart Failure

Meredith A. Brisco, Steven G. Coca, Jennifer Chen et al. · Circulation Heart Failure · 2013 · 142 citations · Full text

Medicine, Cardiology, Internal Medicine +17

Urine Osmolality Estimated Using Urine Urea Nitrogen, Sodium and Creatinine Can Effectively Predict Response to Tolvaptan in Decompensated Heart Failure Patients

Teruhiko Imamura, Koichiro Kinugawa, Shun Minatsuki et al. · Circulation Journal · 2013 · 52 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16